Acetylcholine receptor antibodies (AChR), muscle-specific kinase (MuSK), and lipoprotein-associated protein (LRP4) have been well established as sensitive diagnostic markers and pathogens, in addition to antibodies in the classification of patients with Myasthenia gravis also play a key role [127]. This evidence concerns the gene LRP4 and myasthenia gravis.